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ttp://dx.doi.org/10.1016/j.ajpath.2014.05.025Human extravillous trophoblast (EVT) invades the decidua via integrin receptors and subsequently
degrades extracellular matrix proteins. In preeclampsia (PE), shallow EVT invasion elicits incomplete
spiral artery remodeling, causing reduced uteroplacental blood ﬂow. Previous studies show that pre-
eclamptic decidual cells, but not interstitial EVTs, display higher levels of extracellular matrixe
degrading matrix metalloproteinase (MMP)-9, but not MMP-2. Herein, we extend our previous
PE-related assessment of MMP-2 and MMP-9 to include MMP-1, which preferentially degrades ﬁbrillar
collagens, and MMP-3, which can initiate a local proteolytic cascade. In human ﬁrst-trimester
decidual cells incubated with estradiol, tumor necrosis factor-a (TNF-a) signiﬁcantly enhanced MMP-
1, MMP-3, and MMP-9 mRNA and protein levels and activity measured by real-time quantitative
RT-PCR, ELISA, immunoblotting, and zymography, respectively. In contrast, interferon g (IFN-g)
reversed these effects and medroxyprogesterone acetate elicited further reversal. Immunoblotting
revealed that p38 mitogen-activated protein kinase signaling mediated TNF-a enhancement of MMP-
1, MMP-3, and MMP-9, whereas IFN-g inhibited p38 mitogen-activated protein kinase phosphoryla-
tion. Unlike highly regulated MMP-1, MMP-3, and MMP-9, MMP-2 mRNA and protein expression was
constitutive in decidual cells. Because inﬂammation underlies PE-associated shallow EVT invasion,
these results suggest that excess macrophage-derived TNF-a augments expression of MMP-1, MMP-3,
and MMP-9 in decidual cells to interfere with normal stepwise EVT invasion of the decidua. In
contrast, decidual natural killer cellederived IFN-g reverses such TNF-aeinduced MMPs to protect
against PE. (Am J Pathol 2014, 184: 2549e2559; http://dx.doi.org/10.1016/j.ajpath.2014.05.025)This work was supported by NIH grants R01 HD033937 (C.J.L.) and
5R01HD056123 (S.J.H.).
Disclosures: None declared.Preeclampsia (PE) is a multifactorial disease that affects 6% to
8% of pregnancies in the United States, is responsible for
nearly 8% of maternal deaths, and is a leading cause of peri-
natal morbidity and mortality. Severe PE is a major indication
for early, medically indicated preterm birth.1 The diagnosis of
PE is usually made after 20 weeks by the appearance of
hypertension and proteinuria (maternal syndrome).1
During the ﬁrst 20 weeks of gestation, extravillous tro-
phoblasts (EVTs) arise from cytotrophoblast at the tips of
placental anchoring villi and invade the decidua and upper
third of the myometrium. As they navigate through the
decidua, EVTs enter and facilitate remodeling of spiral ar-
teries and arterioles into large-bore, low-resistance vesselsstigative Pathology.
.that increase uteroplacental blood ﬂow to the intervillous
space requisite for fetal growth and development.2,3 The
onset of PE is strongly associated with shallow decidual EVT
invasion, which leads to incomplete vascular transformation
and reduced uteroplacental blood ﬂow. The resulting hypoxic
placenta4 secretes several putative inducers of endothelial
cell activation and angiogenesis (eg, soluble ﬂt-1 and endo-
glin) into the maternal circulation that elicits vascular dam-
age,5,6 leading to the maternal syndrome.1
Table 1 Summary of Patient Information
Group
Gestational
age (weeks)
Maternal
age (years)
Fetal weight
(grams)
Control (n Z 13) 33.4  1.1 24.8  2.5 1903.8  271.0
PE (n Z 12) 32.6  0.8 29.3  3.1 1548.8  212.0
P value 0.568 0.267 0.32
Data are given as means  SEM. A Student’s t-test was applied to
compare gestational age, maternal age, and fetal weight between control
and PE groups.
PE, preeclampsia.
Lockwood et alInvasion of the decidua by EVT involves sequential
attachment to adhesion molecules, followed by their degra-
dation. Relevant integrin (ITG) heterodimers include ITG-
a1/ITG-b1 and ITG-a5/ITG-b1, which recognize laminin/
collagen IV and ﬁbronectin, respectively, in the decidual
extracellular matrix (ECM),7e9 as well as vascular endothe-
lial cadherin, an endothelial cell receptor.10 In addition to
newly synthesized basement membraneetype proteins, the
decidual ECM also contains signiﬁcant residual interstitial
collagens.11 Degradation of the ECM scaffolding structure is
mediated principally by matrix metalloproteinases (MMPs),
a family of zinc-requiring enzymes that includes collage-
nases, gelatinases, and stromelysins.12 Tissue inhibitors of
MMPs (TIMPs) regulate MMP catalytic activity.13 The
MMPs act in concert with urokinase-type plasminogen acti-
vator (uPA) and its speciﬁc inhibitor, plasminogen activator
inhibitor-1 (PAI-1).14
Previously, our laboratory compared immunostaining of
the decidua from women with PE versus gestational agee
matched control decidua for the presence of the basement
membraneedegrading gelatinases, MMP-2 and MMP-9, as
well as their respective inhibitors, TIMP-1 and TIMP-2, and
found that PE is accompanied by a signiﬁcant increase in
MMP-9 levels in decidual cells, but not in interstitial EVTs.
Unlike MMP-9, no PE-related changes in immunostaining
were observed for either MMP-2 or TIMP-1 or TIMP-2 in
either decidual cells or interstitial EVTs.15 Signiﬁcant subsets
of PE are associated with underlying maternal infections and/
or inﬂammation,16 accompanied by an excess of decidual
macrophages17e20 that are likely sources of elevated levels of
the proinﬂammatory cytokines IL-1b and tumor necrosis
factor-a (TNF-a).21
Consistent with the in situ observations described above
and strong evidence that the pathogenesis of most cases of PE
are initiated in early pregnancy,1 we found that incubation of
primary leukocyte-free, ﬁrst-trimester human decidual cells
with either IL-1b or TNF-a markedly enhanced MMP-9
mRNA and protein expression, unaccompanied by signiﬁ-
cant changes in either MMP-2 or TIMP-1 or TIMP-2 mRNA
and protein expression.15
The current study extends our previous PE-related assess-
ment of MMP-2 and MMP-9 to include MMP-1, which
preferentially degradesﬁbrillar collagens, andMMP-3,which
can initiate a local proteolytic cascade by degrading a wide
array of ECM proteins and by activating the secreted zymo-
genic form of other MMPs, such as proeMMP-1 and
proeMMP-9.13,22 We found the following using a two-tiered
approach of integrating in situ with in vitro observations:
immunoreactive MMP-1 and MMP-3 levels were compared
in decidual cells and interstitial EVTs of decidual placental
sections from women with PE versus gestational
ageematched controls: MMP-1, MMP-3, as well as MMP-2
and MMP-9, were measured in the conditioned medium of
primary, leukocyte-free, ﬁrst-trimester human decidual cells
incubated in parallel with estradiol (E2), whichwas used as the
control incubation for E2 þ medroxyprogesterone acetate2550(MPA) to mimic the pregnant steroid milieu. The steroids
were added alone or with either TNF-a or interferon g (IFN-
g) or TNF-aþ IFN-g. Inclusion of IFN-g, a primary decidual
natural killer (dNK) cell product,23 was prompted by our
recent observations that co-incubation of ﬁrst-trimester
human decidual cells with IFN-g and either IL-1b or TNF-a
synergistically enhances expression of two chemokines,
interferon gamma-induced protein 10 (IP-10; alias CXCL10)
and interferon-inducible T cell alpha chemoattractant (ITAC;
alias CXCL11), that can selectively recruit the peripheral C-
X-C chemokine receptor 3eexpressing CD56bright CD16()
NK cell population to the decidua,24 where they mediate
several pregnancy protective effects.25e27Materials and Methods
Tissues
Immunohistochemical (IHC) studies were performed on
placentas and attached fetal membranes obtained under
Human Investigation Committee approval at Yale Univer-
sity (New Haven, CT) from uncomplicated (n Z 13) or
preeclamptic (nZ 12) pregnancies after cesarean or vaginal
delivery in the absence of signs and symptoms of decidual
hemorrhage (abruption), chorioamnionitis, chronic villitis,
or other indications of underlying acute or chronic inﬂam-
mation, as determined from histological examination. Pa-
tient information is summarized in Table 1. Gestational age
was conﬁrmed by ultrasonography before 20 weeks of
gestation. The PE was deﬁned as the occurrence of elevated
blood pressure (>140/90 mmHg) and proteinuria (0.3 g
protein in a 24-hour urine specimen) identiﬁed on two oc-
casions 6 hours apart after 20 weeks of gestation in women
without hypertension history.
Decidual cell cultures were derived from decidual speci-
mens obtained from eight uncomplicated, elective termina-
tions between 6 and 12 weeks’ gestation under Institutional
Review Board and Human Investigation Committee
approval at Bellevue Hospital (New York, NY) and Yale
University School of Medicine (New Haven, CT), respec-
tively. The decidua was separated, and a small portion was
formalin ﬁxed and parafﬁn embedded and then examined
histologically for signs of underlying acute and chronic
inﬂammation. The remainder was used to isolate decidual
cells.ajp.amjpathol.org - The American Journal of Pathology
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Formalin-ﬁxed, parafﬁn-embedded sections (5 mm thick) were
deparafﬁnized in xylene and rehydrated in a graded series of
ethanol. Immunostaining was preceded by boiling in citrate
buffer (10mmol/L; pH 6.0) for 20minutes to unmask antigenic
sites, followed by immersion in 3% hydrogen peroxide (in 50%
methanol/50% distilled water) for 10 minutes to block endog-
enous peroxidase activity. After several rinses in Tris-buffered
saline (TBS; pH 7.6), slides were incubated in a humidiﬁed
chamber with 5% normal horse or goat serum (Vector Labs,
Burlingame, CA) in TBS for 30minutes at room temperature to
block non-speciﬁc binding. After removing excess serum, se-
rial sections were incubated with primary antibodies [antie
MMP-1 goat polyclonal and antieMMP-3 mouse monoclonal
antibodies, both at 1:100 dilution (R&DSystems,Minneapolis,
MN); anti-vimentin rabbit polyclonal antibody at 1:200 dilu-
tion (Labvision, Waltham, MA); and anti-cytokeratin mouse
monoclonal antibody at 1:400 dilution (Dako Inc., Carpinteria,
CA)] at room temperature for 60 minutes in a humidiﬁed
chamber. For negative controls, sections were treated with
normal mouse IgG1 isotype, normal goat IgG, or normal rabbit
IgG antibodies (Vector Labs). Sections were rinsed in TBS 3
for 5 minutes each, then biotinylated horse anti-mouse or horse
anti-goat or goat anti-rabbit antibodies (Vector Labs) were
added at a 1:400 dilution for 30 minutes at room temperature.
After washing 3 in TBS for 5 minutes each, the antigen-
antibody complex was labeled with a streptavidin-peroxidase
kit or a streptavidin-alkaline phosphatase kit (Vector Labs).
The immunoreaction was developed using the chromogens,
diaminobenzidine (3,3-diaminobenzidine tetrahydrochloride
dehydrate; Vector Labs) for cytokeratin and Fast Red (Vector
Labs) for vimentin, MMP-1, and MMP-3. Sections were
counterstained with hematoxylin (Sigma-Aldrich, St. Louis,
MO) and mounted with Permount (Fisher Chemicals, Spring-
ﬁeld, NJ) on glass slides.
The distribution and intensities of MMP-1 and MMP-3
immunostaining were evaluated semiquantitatively: 0 (no
staining), 1þ (weak, but detectable, staining), 2þ (moderate
or distinct staining), and 3þ (intense staining). For each
tissue, an HSCORE value was derived by taking the sum of
the percentage of cells that stained at each intensity category
and multiplying that value by the weighted intensity of the
staining, using the following formula:
HSCOREZ
X
ðPi  iÞ; ð1Þ
where i represents the intensity score andPi the corresponding
percentage of cells. In each slide, ﬁve different areas were
evaluated microscopically at 40 objective magniﬁcation.
The average score was obtained after evaluation by two in-
vestigators blinded to the samples (W.M. and M.B.).28
Isolation of Decidual Cells
Tissues were minced and digested with 0.1% collagenase
type IV and 0.01% DNase in RPMI 1640 mediumThe American Journal of Pathology - ajp.amjpathol.orgcontaining 20 mg/mL penicillin/streptomycin and 1 mL/mL
amphotericin B (Fungizone; Gibco, Grand Island, NY) in a
37C shaking water bath for 30 minutes. After rinsing with
sterile phosphate-buffered saline (PBS), the digestate was
washed 3 and subjected to consecutive ﬁltration through
100-, 70-, and 40-mm Millipore ﬁlters. Cells were then
resuspended in RPMI 1640 medium, grown to conﬂuence
on polystyrene tissue culture dishes, harvested using trypsin/
EDTA, and analyzed by ﬂow cytometric analysis with anti-
CD45 and anti-CD14 monoclonal antibodies (BD Phar-
mingen, San Diego, CA) to monitor the presence of leu-
kocytes after each passage. After three to four passages, cell
cultures were found to be leukocyte free (<1%).
Monolayers of the decidual cells were vimentin positive
and cytokeratin negative and displayed decidualization-
related morphological and biochemical changes during in-
cubation with MPA, including enhanced expression of
prolactin and PAI-1 and inhibited expression of MMP-1 and
MMP-3 (data not shown). Cell aliquots were frozen in fetal
calf serum/dimethyl sulfoxide (9:1; Sigma-Aldrich) and
stored in liquid nitrogen.
Experimental Decidual Cell Incubations
Thawed cells were incubated in basal medium, a phenol red-
free mix (1:1, v/v) of Dulbecco’s modiﬁed Eagle’s medium
(Gibco) andHam F-12 (FlowLabs, Rockville,MD), with 100
U/mL penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL
amphotericin B (Fungizone), supplemented with 10%
charcoal-stripped calf serum (BMS). After two additional
passages, conﬂuent cultures were incubated in parallel in
BMS containing either 108 mol/L E2 or E2 þ 107 mol/L
MPA (Sigma-Aldrich). Elevated levels of E2 and progester-
one during pregnancy prompted use of E2 as the control for
incubations with E2 þ MPA; the latter was substituted for
progesterone because of its greater stability during culture of
primary human endometrial cells.29 After 7 days, the cultures
were washed twice with PBS to remove residual serum, then
switched to a deﬁned medium (DM) consisting of basal
medium plus Insulin-Transferrin-Selenium (Collaborative
Research, Waltham, MA), 5 mmol/L FeSO4, 50 mmol/L
ZnSO4, 1 nmol/L CuSO4, 20 nmol/L Na2SeO3, trace elements
(Gibco), 50 mg/mL ascorbic acid (Sigma-Aldrich), and 50 ng/
mL epidermal growth factor (Becton-Dickinson, Bedford,
MA), with either vehicle control (0.1% ethanol) or steroids,
added with or without 1.0 ng/mL each of TNF-a, IFN-g, or
TNF-a þ IFN-g (R&D Systems). To identify the signaling
pathways that regulate MMP expression in the cultured ﬁrst-
trimester decidual cells, the experimental incubations were
repeated in the presence of speciﬁc inhibitors of the NF-kB
pathway (NF-kB activation inhibitor III at 105 mol/L), the c-
Jun N-terminal kinase mitogen-activated protein kinase
(MAPK) pathway (SP600125 at 105 mol/L), or the extra-
cellular signaleregulated kinase 1/2 MAPK (PD98059 at
2 105mol/L), mammalian target of rapamycin (rapamycin
at 107 mol/L), or p38 MAPK (SB203580 at 105 mol/L)2551
Lockwood et alpathway (Calbiochem-EMD; Millipore, San Diego, CA).
After the test period (6 hours for RT-PCR analysis, 15minutes
for Western blot signaling pathway analysis, or 24 hours for
both Western blot and ELISA measurements of conditioned
DM), the cells were harvested by scraping into ice-cold PBS,
pelleted, and extracted in ice-cold lysis buffer. Conditioned
DMsupernatants and cell lysates were stored at80Cbefore
ﬁnal RNA or protein extraction.
Reverse Transcription
Total RNA from ﬁrst-trimester decidual cells was isolated
using the Qiagen Mini Kit (Qiagen, Valencia, CA), and
cleanup of RNA samples was performed using the RNeasy
MinElute Cleanup Kit (Qiagen), according to the manufac-
turer’s instructions. To eliminate genomic DNA contamina-
tion, isolated total RNA was treated with DNase I (Qiagen).
Reverse transcription was performed using the RETROscript
kit (Ambion, Austin, TX) in two steps: Template RNA was
initially incubated with random dexamer primers at 85C for
3 minutes to eliminate any secondary structures, followed by
a reverse transcription reaction, which was performed at
42C for 1 hour in 2 mL of 10 reverse transcriptase buffer, 4
mL of 1.25 mmol/L dNTP mix, 1 mL of RNase inhibitor (10
U/mL), and 1 mL of Moloney murine leukemia virus-RT (100
U/mL). Subsequently, the Moloney murine leukemia virus-
RT enzyme was inactivated at 92C for 10 minutes.
qPCR for MMP-1, MMP-3, and MMP-9
Quantitative real-time PCR (qPCR) was performed using
the TaqMan Gene Expression Assay Kits for MMP-1,
MMP-3, and MMP-9 (MMP-1, MMP-3, and MMP-9 Taq-
Man ID numbers Hs00899658_m1, Hs00968305_m1, and
Hs00234579_m1, respectively; Applied Biosystems, Grand
Island, NY), according to the manufacturer’s protocol. In
brief, 10 mL of TaqMan 2 Universal PCR Master Mix was
combined with 8 mL of nuclease-free water, 1 mL of 20
TaqMan MicroRNA Assay mix, and 1 mL of cDNA in the
PCR tube. Ampliﬁcation used 40 cycles of PCR in Applied
Biosystems 7500 Real-Time PCR Detection System
(Applied Biosystems), with the following program: initial
denaturation at 95C for 10 minutes, followed by 40 cycles
at 95C for 15 seconds and 60C for 60 seconds. All re-
actions were run in triplicate. Expression of the target
mRNAs was normalized to b-actin levels, and the 2DDCT
method was used to calculate relative expression levels.
Biochemical Assays
Total cell protein levels were measured by a modiﬁed
Lowry assay (Bio-Rad Laboratories, Hercules, CA). Com-
mercial ELISA kits were used to measure total, noncom-
plexed immunoreactive levels, each of MMP-1, MMP-2,
MMP-3, and MMP-9, in the decidual celleconditioned me-
dium, according to the manufacturer’s instructions2552(Quantikine kits; R&D Systems). The sensitivity of the
MMP-1 ELISA is 0.021 ng/mL, and that of the MMP-3
ELISA is 0.009 ng/mL. The MMP-1 assay coefﬁcients of
variation for intra-assay and interassay are 4.6% and 9.4%,
respectively. The MMP-3 assay coefﬁcients of variation for
intra-assay and interassay are 6.1% and 7.8%, respectively.
Both MMP-2 and MMP-9 ELISAs have sensitivities of
0.16 ng/mL. The MMP-2 assay coefﬁcients of variation for
intra-assay and interassay are 4.8% and 7.7%, respectively.
The MMP-9 assay coefﬁcients of variation for intra-assay
and interassay are 2.3% and 7.5%, respectively.
Substrate Gel Zymography
Gel zymography, using gelatin as the substrate within the gel,
detected the proteolytic activity of MMP-2 and MMP-9,
whereas casein was used to detect the proteolytic activity of
MMP-1 and MMP-3. Conditioned DM from decidual cell
cultures was centrifuged, and for zymograms in which the
proforms and latent forms of MMP-2 and MMP-9 were
evaluated, the supernatants were pretreated with dimethyl
sulfoxide at a concentration of<7% of the total volume, with
and without 2 mmol/L aminophenylmercuric acetate
(APMA; Sigma-Aldrich) at 37C for 2 hours; APMA con-
verts latent (pro) forms of the MMPs to their active forms.
The reaction was stopped by mixing the samples 1:1 with
nonreducing zymogram sample buffer (Bio-Rad Labora-
tories) and then incubating for 10 minutes at room tempera-
ture. This step also blocks the APMA reaction. Samples were
loaded onto a 10% gelatin zymogram gel or a 12% casein
zymogram gel (Bio-Rad Laboratories), then electro-
phoresed for 1.75 hours in Tris-glycine SDS running buffer.
To enable the enzymes to renature, the gel was incubated for
45 minutes in 2.5% Triton X-100 (Bio-Rad Laboratories) at
room temperature and incubated in zymogram development
buffer (Bio-Rad Laboratories) for 30 minutes, and then
placed in fresh zymogram development buffer overnight at
37C. The gel was stained with 0.5% Coomassie Brilliant
Blue (Sigma-Aldrich) solution of methanol/acetic acid/
water (40:10:50, v/v) for 2 hours at room temperature, and
then destained with methanol/acetic acid/water (30:10:60,
v/v) for 4 hours at room temperature. The presence of clear
bands in the gels at the appropriate molecular weights re-
ﬂects gelatinolytic activity of the latent (pro) and active
forms of MMP-2 and MMP-9 and the caseinolytic activity
of MMP-1 and MMP-3.
Immunoblotting
Immunoblot analysis was performed on concentrated condi-
tioned DM supernatants, which were diluted 1:6 in nonre-
ducing Laemmli 6 sample buffer (Boston Bioproducts,
Boston, MA) and then boiled for 4 minutes. The centrifuged
media were subjected to SDS-PAGE on a 7.5% Tris-HCl gel
(Bio-Rad Laboratories), with subsequent electroblotting
transfer onto a 0.45-mm nitrocellulose membrane (Bio-Radajp.amjpathol.org - The American Journal of Pathology
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overnight in TBS (Fisher, Fairlawn, NJ) with 4% nonfat dry
milk and then incubated for 2 hours with mouse anti-human
MMP-1, MMP-2, MMP-3, or MMP-9 monoclonal antibodies
(R&D Systems). Membranes were rinsed in PBS and 0.1%
Tween 20 before and after incubation with horseradish per-
oxidaseeconjugated anti-mouse IgG (ICN Biomedicals,
Aurora, OH). Chemiluminescence was detected with electro-
chemiluminescence reagents (Perkin-Elmer Life Sciences,
Boston, MA) and autoradiography ﬁlm (Amersham Pharma-
cia, Pittsburgh, PA), according to the manufacturer’s in-
structions. The membranes were then rinsed as above and
incubated in stripping buffer (100 mmol/L 2-mercaptoethanol,
2%SDS, and 62.5mmol/L Tris-HCl, pH 6.7) for 30minutes at
50C with subsequent rinsing and reblocking, as indicated
above, with b-actin.
Statistical Analysis
MMP ELISA results were examined by the Shapiro-Wilk
normality test, followed by the Wilcoxon signed rank test.
Immunoblotting, RT-qPCR, and immunostaining HSCORE
results were normally distributed, as determined by
Kolmogorov-Smirnov test, and analyzed by one-way anal-
ysis of variance, followed by testing post hoc with the
Holm-Sidak method. In comparisons of control with treat-
ment groups, P < 0.05 is accepted as statistically signiﬁcant.
Statistical calculations used SigmaStat software version 3.0
(Systat Software, San Jose, CA).
Results
Immunostaining for MMP-1 and MMP-3 in Preterm
Control and Gestational AgeeMatched Preeclamptic
Decidua
In the immunostained sections of decidua basalis, vimentin-
expressing decidual cells were readily distinguished from
adjacent cytokeratin-expressing interstitial EVTs (Figure 1, A
and B). Both decidual cells and interstitial EVTs expressed
immunoreactive MMP-1 (Figure 1, C and D) and MMP-3
(Figure 1, E and F). However, the PE specimens displayed
greater immunoreactivity than gestational ageematched con-
trols for MMP-1 (Figure 1, D versus C) andMMP-3 (Figure 1,
F versus E). The HSCORE values conﬁrmed this assessment
by indicating signiﬁcantly enhanced PE-related immuno-
staining in the decidual cells for MMP-1 (mean  SEM,
171.67  15.17) versus preterm controls (124.23  10.44;
PZ 0.016) (Figure 1G). In contrast, the HSCORE values for
MMP-1 in interstitial EVTs were not signiﬁcantly different
between PE (mean SEM, 95.00 8.84) and preterm control
(mean  SEM, 78.46  8.54; P Z 0.19) specimens
(Figure 1G). Similarly, HSCORES for MMP-3 immuno-
staining (Figure 1G) in decidual cells of PE specimens
(mean SEM, 199.67 15.18) were signiﬁcantly higher than
those in preterm controls (149.08  11.29; P Z 0.013), andThe American Journal of Pathology - ajp.amjpathol.orgagain no signiﬁcant differences were evident in interstitial
EVTs between PE (101.67  9.03) and preterm control
(81.54  9.60) specimens (P Z 0.14) (Figure 1G). The
HSCORE values also indicate that the expression of each
MMP was signiﬁcantly higher in decidual cells than in inter-
stitial EVTs in both preterm control and PE samples
(P < 0.001) (Figure 1G).
MMP Protein Expression in Decidual Cell Monolayer
Cultures
MMP-1 and MMP-3 Expression
The individual and combined effects of steroids and cyto-
kines on the output of MMP-1 (Figure 2A) and MMP-3
(Figure 2B) by leukocyte-free, ﬁrst-trimester decidual cells
are shown. As detailed in Materials and Methods, E2 was
used as the control for parallel incubations with E2 þ MPA,
which simulates the pregnant steroid milieu.
Compared with MMP-1 values obtained by treatment with
E2 alone (0.016 0.006 ng/mL per mg of cell protein, nZ 6),
MMP-1 output was elevated to 0.238  0.055 ng/mL per mg
protein (15-fold increase; P < 0.05) by addition of 1 ng/mL
of TNF-a (Figure 2A). Despite a lack of a response to 1 ng/
mL of IFN-g alone (0.016  0.004 ng/mL per mg protein),
co-incubating IFN-g with TNF-a blunted the effect of the
latter by 43.4% (P< 0.05). Compared with treatment with E2
alone, the addition of MPA signiﬁcantly reduced MMP-1
output (0.002  0.001 ng/mL per mg of cell protein) by
85.2% (P < 0.05). This MPA-mediated inhibitory effect is
also evident in the blunted response to TNF-a alone (81%) or
to TNF-a þ IFN-g (85.6%) when each is compared with
cultures exposed to E2 alone. Addition of IFN-g alone also
signiﬁcantly inhibited MMP-1 production induced by TNF-a
by 57.13% in cultures exposed to E2 þ MPA.
Compared with E2 alone (0.053  0.021 ng/mL per mg of
cell protein, n Z 6), co-incubation with 1 ng/mL of TNF-a
elevated MMP-3 output to 0.517  0.143 ng/mL per mg pro-
tein, representing a 10-fold increase (P < 0.05) (Figure 2B).
Despite a nonsigniﬁcant response to 1 ng/mL of IFN-g alone
(0.056 0.025 ng/mL per mg protein), co-incubation with IFN-
g signiﬁcantly blunted TNF-aemediated up-regulation by
40.6% (P < 0.05). In parallel incubations with E2 þ MPA,
MMP-3 output (0.022  0.007 ng/mL per mg of cell protein)
was signiﬁcantly reduced by 58.3% (P < 0.05) compared with
E2 alone. This MPA-mediated inhibitory effect in co-
incubations with E2 is also evident in the diminished response
to TNF-a alone (52.2% inhibition) or to TNF-a þ IFN-g
(74.3% inhibition). Moreover, IFN-g signiﬁcantly inhibited
MMP-3 production induced by TNF-a with E2 þ MPA by
68%.
The decidual cell-conditioned DM displays caseinolytic
activity in the molecular weight range corresponding to
MMP-1 and MMP-3 (Figure 3). Consistent with the ELISA
results (Figure 2), in incubations with E2, the addition of
TNF-a markedly enhanced this caseinolytic zone. Although
IFN-g alone elicited a minimal effect, close inspection2553
Figure 1 The IHC analysis of MMP-1 and MMP-3 expression in decidual
tissues from preterm specimens. Decidual cells (arrowheads) and interstitial
EVTs (arrows) are distinguished by vimentin (red) and cytokeratin (brown)
immunostaining, respectively, in gestational ageematched decidua of women
serving aspretermcontrols (A) orwithPE (B).MMP-1 expression (red) inpreterm
control (C) and preeclamptic decidual cells (D), and MMP-3 expression (red) in
preterm control (E) and preeclamptic decidual cells (F). G: HSCORE values for
MMP-1 and MMP-3 expression. Both decidual cells and interstitial trophoblasts
are compared between preterm controls (Cont; n Z 13) and those from PE
specimens (nZ 12). Data represent means SEM. *P < 0.02, **P< 0.002.
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Figure 2 Effects of TNF-a or IFN-a or TNF-aþ IFN-a incubatedwith E (E2)
or EM (E2 þ MPA) on MMP-1 (A) and MMP-3 (B) output by ﬁrst-trimester
decidual cell monolayers. Conﬂuent, leukocyte-free decidual cells were
primed for 7 days in BMS with 108 mol/L E2, or E2 þ 107 mol/L MPA, and
then switched to DM with corresponding steroid(s), with or without 1 ng/mL
each of TNF-a (T) or IFN-a (IF) or TNF-aþ IFN-a (TIF) for 24 hours. Results are
measured by speciﬁc ELISAs in conditioned DM supernatants and normalized
to cell protein. Data represent means SEM. *P< 0.05, **P< 0.01 versus E;
yP < 0.05 , yyP < 0.01 versus EM; zP < 0.05 versus corresponding treatment
without IF; xP < 0.05 versus corresponding treatment without M (nZ 6).
Lockwood et alindicated inhibition of the TNF-aeinduced lytic zone dur-
ing co-incubation with IFN-g. In the parallel incubation
with E2 þ MPA, the TNF-aemediated lytic zone is mark-
edly reduced compared with E2 alone, and co-incubation
with IFN-g virtually eliminates the TNF-aemediated
caseinolytic effect.2554MMP-2 and MMP-9 Expression
The effects (separate and interactive) of steroids and cyto-
kines on the output of MMP-2 (Figure 4A) and MMP-9
(Figure 4B) by leukocyte-free, ﬁrst-trimester decidual cells
are shown. We previously reported15 that TNF-a and IL-1b
each signiﬁcantly enhance MMP-9 expression in parallel
incubations with E2 or E2 þ MPA, whereas MMP-2
expression was unchanged irrespective of experimental con-
dition. Therefore, E2 þ MPA, which represents the pregnant
steroid milieu, was used as the control incubation. Basal
(control) MMP-2 output was similar in all of the experimental
treatments (Figure 4A). In contrast with constitutive MMP-2
expression, basal (control) MMP-9 output (0.066 0.016 pg/
mL per mg of cell protein) was essentially unchanged during
incubation with IFN-g alone (0.074 0.022 pg/mL per mg of
cell protein), but markedly up-regulated by incubation with
TNF-a alone to 14.724  6.275 pg/mL per mg of cell protein
(225-fold increase) (Figure 4B). As displayed above for the
expression of MMP-1 (Figure 2A) and MMP-3 (Figure 2B),
co-incubation of the decidual cells with IFN-g signiﬁcantly
lowered TNF-aeinduced effects on MMP-9 levels by
81.07% to 2.787  1.573 pg/mL per mg of cell protein.
The zymograms were derived from conditioned DM ob-
tained after parallel incubations with E2 þ MPA aloneajp.amjpathol.org - The American Journal of Pathology
Figure 3 Substrate gel zymography of MMP-1 and MMP-3 activity by
ﬁrst-trimester decidual cell monolayers. Conﬂuent, leukocyte-free decidual
cells were incubated for 7 days in BMS containing 108 mol/L E2 or E2 þ
107 mol/L MPA, and then switched to DM with corresponding steroid(s),
with or without 1 ng/mL each of TNF-a or IFN-a or TNF-a þ IFN-a for 24
hours. Conditioned DM was run on a 12% casein gel zymogram and then
subjected to renaturing and staining procedures (as described in Materials
and Methods). Proteolytic activity of MMPs is indicated by clear bands in
the darkly stained gel. Neg, negative.
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Figure 4 Effects of TNF-a or IFN-a or TNF-a þ IFN-a incubated with
E2 þ MPA on secreted MMP-2 and MMP-9 levels by ﬁrst-trimester decidual
cell monolayers. Conﬂuent, leukocyte-free decidual cells were incubated for
7 days in BMS containing 108 mol/L E (E2) þ 107 mol/L M (MPA), and
then switched to DM with corresponding steroid(s), with or without 1 ng/
mL each of TNF-a (T) or IFN-a (IF) or TNF-a þ IFN-a (TIF) for 24 hours.
MMP-2 (A) and MMP-9 (B) levels were measured by speciﬁc ELISAs in
conditioned DM supernatants and normalized to cell protein (nZ 8). Data
represent means  SEM. *P < 0.05, **P < 0.01.
IFN-g Reverses Elevated MMP Levels in PE(control) or E2 þ MPA plus IFN-g, or TNF-a, or IFN-g þ
TNF-a (Figure 5). Decidual cell-conditioned DM contained
discrete zones of gelatinolytic activity that corresponded to
MMP-2 and MMP-9 at the appropriate molecular weights
(72 and 92 kDa, respectively, in the absence of APMA)
(Figure 5). Pretreatment of the decidual cell-conditioned
medium with APMA shifted virtually all of the pro-MMP
forms to the active MMP forms (66 kDa for MMP-2 and
86 kDa for MMP-9). Consistent with the constitutive
expression of MMP-2 and the regulated expression of MMP-
9, indicated by ELISA (Figure 4), neither TNF-a nor IFN-g
affected the magnitude of MMP-2emediated proteolysis,
whereas expression of both the pro- and active forms of
MMP-9 was markedly increased by TNF-a, with this in-
duction blunted by co-incubation with IFN-g.
Transcriptional Regulation of TNF-aeInduced MMP-1,
MMP-3, and MMP-9 Expression in First-Trimester
Decidual Cells by IFN-g
The RT-PCR results (Figure 6) showed that steady-state
mRNA levels for MMP-1, MMP-3, and MMP-9 corre-
spond to changes in protein levels measured by ELISA
(Figures 2 and 4) and substrate gel zymography (Figures 3
and 5). Speciﬁcally, compared with incubations with E2 þ
MPA, treatment of the ﬁrst-trimester decidual cells with
TNF-a signiﬁcantly enhanced MMP-1, MMP-3, and MMP-
9 mRNA expression by sixfold, threefold, and sevenfold,
respectively. Moreover, the addition of IFN-g signiﬁcantly
blunted TNF-aeinduced MMP-1, MMP-3, and MMP-9
expression by 65%, 60%, and 66%, respectively (Figure 6).
p38 MAPK Signaling Mediates TNF-a Induction of MMP
Expression and the Inhibitory Effects of IFN-g
Cell lysates derived from ﬁrst-trimester decidual cell mono-
layers incubated in parallel with E2 or E2 þ MPA displayedThe American Journal of Pathology - ajp.amjpathol.orgindividual bands migrating with the expected molecular
weights for MMP-1 (54 kDa), MMP-3 (54 kDa), MMP-2 (62
kDa), and MMP-9 (92 kDa) (Figure 7A). Compared with the
constitutive expression ofMMP-2, the magnitude ofMMP-1,
MMP-3, and MMP-9 expression was enhanced by TNF-a,
with this effect blunted by co-incubation with SB203580, a
p38 MAPK inhibitor. No such effect was observed for TNF-
a, with or without other speciﬁc signaling pathway inhibitors
for NF-kB (NF-kB III), c-Jun N-terminal kinase MAPK
(SP600125), extracellular signaleregulated kinase MAPK
(PD98059), or mammalian target of rapamycin (rapamycin)
(results not shown).
The ELISA results for MMP-1 and MMP-3 (Figure 2)
and MMP-9 (Figure 4) were conﬁrmed (Figure 7B) and
indicated that IFN-g inhibited TNF-a induction of each
MMP. We postulated that this IFN-gemediated anti-
inﬂammatory effect resulted from inhibition of the p38
MAPK signaling pathway. This hypothesis was conﬁrmed
as in parallel incubations of decidual cells treated with E2 or
with E2 þ MPA, TNF-a signiﬁcantly increased the phos-
phorylated form of p38 MAPK compared with the respec-
tive control incubations (either E2 alone or with E2 þ MPA2555
Figure 5 Substrate gel zymography of MMP-2e and MMP-9emediated
gelatinase activity by ﬁrst-trimester decidual cell monolayers. Conﬂuent,
leukocyte-free decidual cells were incubated for 7 days in BMS containing
108 mol/L E2 þ 107 mol/L MPA (control) and then switched to DM with
corresponding steroid(s), with or without 1 ng/mL of TNF-a or IFN-a or
TNF-a þ IFN-a for 24 hours. Aliquots of conditioned DM were subjected to
gelatin zymography after pretreatment with and without APMA, which
converts the pro-forms (Pro) of the MMPs to their active forms (Act). CON,
control; NEG, negative control.
Figure 6 Transcriptional regulation of MMPs by TNF-a or IFN-a or TNF-
a þ IFN-a incubated with E (E2) þ MPA by ﬁrst-trimester decidual cells.
Conﬂuent, leukocyte-free decidual cells were incubated for 7 days in 108
mol/L E2 þ 107 mol/L MPA in BMS (control) and then switched to DM with
corresponding steroid(s), with or without 1 ng/mL of TNF for 6 hours.
Extracted RNA subjected to RT-qPCR analysis of MMP-1, MMP-3, and MMP-9
mRNA. Data represent means  SEM (n Z 3). *P < 0.05, **P < 0.01.
Lockwood et alalone) (Figure 7C). In contrast, addition of IFN-g reduced
TNF-aeinduced phospho-p38 MAPK. No experimental
condition affected total p38 MAPK levels.
Discussion
Human blastocyst-derived EVTs invade a decidua composed
of decidual cells (40%) and immune cells dominated by dNK
cells (30%) andmacrophages (15%).30e32 Conversion of spiral
arteries and arterioles to low-resistance, high-capacity vessels
that increase uteroplacental blood ﬂow to the developing fetal-
placental unit was attributed to ﬁbrinoid-embedded vascular
EVTs.33 Newer evidence indicates that dNK cells accumulated
around spiral arteries in the absence of EVTs26,34 initiate early
vascular remodeling steps, including vascular dilation, endo-
thelial hyperplasia, and vacuolization of medial smooth muscle
cells by elaborating MMP-2 and MMP-9,35 IFN-g, and the
angiogenic factors vascular endothelial cell growth factor-C
and angiopoietins 1 and 2.36 Trophoblasts inﬂuence early
vascular remodeling by recruiting circulating NK cells to the
decidua. Thus, EVTs lining spiral arteries express stromal
cellederived factor-1 (alias CXCL12), which binds to CCR4
expressed at the surface of the minority CD56brightCD16-
circulating NK cells to promote their recruitment.33
Previously, we17 and others37 found that preeclamptic
decidua contains a macrophage excess. Macrophage-derived
TNF-a is implicated in mediating PE-related shallow EVT
invasion of the decidua directly by inducing EVT apoptosis38
and/or indirectly by reciprocally inhibiting expression of
trophoblast-bound uPA and increasing levels of PAI-1, which
inactivates uPA bound to its receptor at the leading edge of
EVT invasion.39 Moreover, macrophage-derived TNF-a
stimulates ﬁrst-trimester decidual cells to secrete factors that
activate macrophages,20 which display enhanced activity in
inducing EVT apoptosis20 and inhibiting EVT invasion.19
Substantial evidence established that EVTedecidual cell
interactions bear the primary responsibility of mediating the
later and more decisive changes in spiral artery remodeling.40
Investigations of normal and immortalized ﬁrst-trimester
EVTs indicate that EVT migration and invasion are modu-
lated by several factors expressed by both trophoblasts and2556decidual cells at the maternal-fetal interface. These include
insulin-like growth factor-2 (IGF2), its IGF2 mannose-6
phosphate receptor,41 IGF-binding protein 1,42,43 prosta-
glandin E2 and its EP1 receptor,
44 and transforming growth
factor-b isoforms and decorin, which stores transforming
growth factor-b in the decidual ECM.45e47
Human EVTs and cancer cells display similar prolifera-
tive, angiogenic, and migratory phenotypes48 mediated by
several common molecular circuits.49 Both human EVT and
tumor cell invasion involve sequential ITG-mediated adher-
ence to, and then proteolysis of, speciﬁc proteins in the host
tissue ECM.49,50 By comparison, human EVT invasion of
decidua is under far more stringent spatial and temporalajp.amjpathol.org - The American Journal of Pathology
Figure 7 Role of p38 MAPK in regulating MMP-1, MMP-2, MMP-3, and
MMP-9 expression by TNF-a and IFN-g in ﬁrst-trimester cultured decidual
cells. Parallel incubation of conﬂuent leukocyte-free decidual cells  TNF-a
(1 ng/mL)  SB203580 (SB; 105 mol/L; p38 MAPK inhibitor) (A);  TNF-a
(1 ng/mL)  IFN-g (1 ng/mL) (B);  TNF-a (1 ng/mL)  IFN-g (1 ng/mL)
in DM containing E2 alone (10
8 mol/L) or E2 þ MPA (108 mol/L þ 107
mol/L) for 24 hours (A and B) or for 15 minutes (C). ph-p38 MAPK,
phosphorylated (active) p38 MAPK; To-p38 MAPK, total p38 MAPK (nZ 3).
Figure 8 Schematic representation of molecular mechanisms mediating
the separate and interactive regulatory effects of TNF-a and IFN-g on MMP
expression in human ﬁrst-trimester decidual cells. Binding of TNF-a to its
cell surface receptor (TNFaR) increases MMP-1, MMP-3, and MMP-9
expression by stimulating p38 MAPK phosphorylation (activity) in
decidual cells, whereas IFN-g bound to its cell surface receptor blocks TNF-
aeinduced p38 phosphorylation to protect against MMP-mediated ECM
degradation in the decidua.
IFN-g Reverses Elevated MMP Levels in PEcontrol because it is limited to the decidua and proximal
myometrium and ended by midgestation.49e51 Initial studies
stressed the importance in promoting tumor cell invasiveness
of the expression of uPA52 and MMPs, particularly MMP-2
and MMP-9,53,54 acting in concert with the respective
modulating actions of PAI-152 and TIMPs.54 Recent IHC and
in situ hybridization observations in human tissues, sup-
ported by studies in transgenic cancer mouse models,
switched the emphasis away from tumor cells to the host
stromal cells as major contributors of uPA and MMPs during
tumor growth, invasion, and metastasis, while indicating that
tumor cells act primarily to stimulate adjacent stromal cells to
synthesize key regulators of ECM turnover.55,56 Moreover,
correcting a misconception that overexpression of speciﬁc
MMPs, either by tumor cells or adjacent host stromal cells,
always promotes tumor growth, reports of tumor formation in
transgenic mice with either targeted overexpressed or ablated
MMPs revealed that overexpression of speciﬁc MMPs at
either the primary or metastatic site paradoxically protects
against multiple stages of cancer progression.57
By comparison with the complex involvement of MMP
expression by both tumor and host cells in determining
invasiveness of the former, in PE, the focus of impaired
decidual EVT invasion has generally remained ﬁxed on
MMP expression by trophoblasts.50,51,58,59 Initially,The American Journal of Pathology - ajp.amjpathol.orgtrophoblasts from preeclamptic pregnancies were reported
to express lower levels of MMP-2 and MMP-9 than their
normal counterparts.60 Subsequently, integration of micro-
array analysis, together with double-labeled immunoﬂuo-
rescence staining, revealed that, among several genes
implicated in mediating trophoblast differentiation and in-
vasion, MMP-1 expression alone was signiﬁcantly and
strikingly reduced in EVTs in cases of PE and intrauterine
growth restriction or PE plus intrauterine growth restriction
versus gestational ageematched control specimens.61
Searching for a relationship between PE and MMP
expression by the predominant cell types at the maternal-fetal
interface, we observed signiﬁcantly increased immunoreactive
MMP-9 in vimentin-positive decidual cells of gestational
ageematched preeclamptic versus control decidual sections;
we did not observe this in decidual celleexpressed MMP-2,
and there were no PE-related changes in immunoreactive
MMP-2 or MMP-9 levels in neighboring cytokeratin-positive
interstitial EVTs.15 In parallel with previous MMP-9 obser-
vations, the current study ﬁnds signiﬁcantly elevated immu-
noreactive MMP-1 and MMP-3 levels in PE-associated
decidual cells, with no changes in adjacent interstitial EVTs. In
situeincreased MMP-1, MMP-3, and MMP-9 immunostain-
ing in the preeclamptic decidua is consistent with disruption of
ITG-mediated EVT invasion. These observations prompted
incubations of leukocyte-free, ﬁrst-trimester human decidual
cells with E2 þ MPA to mimic the pregnant steroid milieu,
with added TNF-a tomimic the proinﬂammatorymilieu of PE.
Consistent with our previous and current IHC observations
of preeclamptic versus control decidual specimens, ELISA
measurements demonstrated that, unlike constitutively
expressed MMP-2 expression, TNF-a signiﬁcantly increased
MMP-9 levels. The current study observes similar TNF-ae
augmented decidual cell MMP-1 and MMP-3 expression.2557
Lockwood et alHistological and genetic studies in mice indicate that dNK
cell-derived IFN-g mediates spiral artery remodeling, similar
to that described in early pregnant human decidua.62 Report-
edly, early pregnant human dNK cells are a major source of
IFN-g.63 We determined that IFN-g is crucial in mediating
decidual cell recruitment of peripheral NK cells via enhanced
expression of the chemokines IP-10 and ITAC.23 The well-
documented role of NK cells in promoting several preg-
nancy protective effects in mice64,65 and humans25e27 sug-
gested that IFN-g may also counteract proinﬂammatory
cytokine-enhanced aberrant MMP expression in ﬁrst-
trimester decidual cells, which are implicated in promoting
the shallow EVT invasion of PE. Consistent with this suppo-
sition, the current ELISA measurements indicate that, in ﬁrst-
trimester decidual cells incubated with E2 þ MPA, co-
incubation with IFN-g virtually eliminated the marked up-
regulation of MMP-1, MMP-3, and MMP-9 by TNF-a, as
conﬁrmed by substrate gel electrophoresis and RT-qPCR.
Immunoblotting revealed that p38 MAPK signaling medi-
ates TNF-aeinduced MMP-1, MMP-3, and MMP-9 expres-
sion, whereas IFN-g signiﬁcantly reverses these TNF-a effects
by inhibiting p38 MAPK phosphorylation.
In summary, new in situ and in vitro observations indicate
that aberrant TNF-aeaugmented expression of MMP-1,
MMP-3, and MMP-9 by decidual cells could interfere with
normal stepwise ITG-mediated EVT invasion of the decidua to
promote the later onset of PE. In addition, IFN-g reverses this
abnormal TNF-aeenhanced expression (Figure 8). These
IFN-g effects are consistent with restoration of normal step-
wise EVT invasion of the decidua and suggest a mechanism by
which dNK cellederived IFN-g counteracts the shallow
trophoblast invasion strongly implicated in impaired decidual
vascular remodeling, leading to the later development of PE.1References
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